Browsing Tag
Hypertrophic Cardiomyopathy Treatment
1 post
Tenaya Therapeutics’ TN-201 demonstrates tolerability and protein expression in early HCM trial
Tenaya Therapeutics, a clinical-stage biotechnology company, has released promising interim results from its MyPEAK-1 Phase 1b/2 clinical trial…